戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ing 2003 patients underwent a small (3-5 mm) endoscopic sphincterotomy.
2 he optimal duration of dilation for combined endoscopic sphincterotomy and balloon dilation for the r
3 A balloon dilation time of 30 s for combined endoscopic sphincterotomy and balloon dilation reduced t
4 cess rates and complications associated with endoscopic sphincterotomy and endoscopic balloon dilatio
5 interventions (eg, endoluminal resection and endoscopic sphincterotomy) and be familiar with the endo
6 ated with temporary biliary stent placement, endoscopic sphincterotomy, and broad-spectrum antibiotic
7 stic ERCP and IOC, complications of ERCP and endoscopic sphincterotomy, and complications of surgery)
8 ate of extraction of CBDS who had treated by endoscopic sphincterotomy/endoscopic papillary balloon d
9 doscopic retrograde cholangiopancreatography/endoscopic sphincterotomies (ERCP/ES) in patients who ha
10 e bile duct stones (> 15 mm) by conventional endoscopic sphincterotomy (EST) and endoscopic papillary
11 popularity of laparoscopic cholecystectomy), endoscopic sphincterotomy has been used increasingly for
12                    After the first report of endoscopic sphincterotomy in 1974, therapeutic uses were
13      We evaluated the therapeutic effects of endoscopic sphincterotomy in patients with recurrent acu
14                                              Endoscopic sphincterotomy is commonly used to remove bil
15                                              Endoscopic sphincterotomy is the established treatment f
16 ectomy with selective postoperative ERCP and endoscopic sphincterotomy only if a CBD stone was presen
17 (P = 0.0001, OR 2.41, 95% CI: 1.05-5.51) and endoscopic sphincterotomy (P = 0.038, OR 2.85, 95% CI: 1
18 riampullary perforations that develop during endoscopic sphincterotomy remains a topic of discussion.
19 oung age, no statin use, history of PEP, and endoscopic sphincterotomy were found to be significantly